236 related articles for article (PubMed ID: 22915828)
1. Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development.
Lu T; Lin WJ; Izumi K; Wang X; Xu D; Fang LY; Li L; Jiang Q; Jin J; Chang C
Mol Endocrinol; 2012 Oct; 26(10):1707-15. PubMed ID: 22915828
[TBL] [Abstract][Full Text] [Related]
2. Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH).
Lai KP; Huang CK; Fang LY; Izumi K; Lo CW; Wood R; Kindblom J; Yeh S; Chang C
Mol Endocrinol; 2013 Oct; 27(10):1617-31. PubMed ID: 23893956
[TBL] [Abstract][Full Text] [Related]
3. Increased infiltrated macrophages in benign prostatic hyperplasia (BPH): role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation.
Wang X; Lin WJ; Izumi K; Jiang Q; Lai KP; Xu D; Fang LY; Lu T; Li L; Xia S; Chang C
J Biol Chem; 2012 May; 287(22):18376-85. PubMed ID: 22474290
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor roles in the development of benign prostate hyperplasia.
Izumi K; Mizokami A; Lin WJ; Lai KP; Chang C
Am J Pathol; 2013 Jun; 182(6):1942-9. PubMed ID: 23570837
[TBL] [Abstract][Full Text] [Related]
5. Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer.
Wen S; Chang HC; Tian J; Shang Z; Niu Y; Chang C
Am J Pathol; 2015 Feb; 185(2):293-301. PubMed ID: 25432062
[TBL] [Abstract][Full Text] [Related]
6. Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling.
Fang LY; Izumi K; Lai KP; Liang L; Li L; Miyamoto H; Lin WJ; Chang C
Cancer Res; 2013 Sep; 73(18):5633-46. PubMed ID: 23878190
[TBL] [Abstract][Full Text] [Related]
7. Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling.
Lin TH; Izumi K; Lee SO; Lin WJ; Yeh S; Chang C
Cell Death Dis; 2013 Aug; 4(8):e764. PubMed ID: 23928703
[TBL] [Abstract][Full Text] [Related]
8. New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells.
Lai KP; Huang CK; Chang YJ; Chung CY; Yamashita S; Li L; Lee SO; Yeh S; Chang C
Am J Pathol; 2013 Feb; 182(2):460-73. PubMed ID: 23219429
[TBL] [Abstract][Full Text] [Related]
9. Evidence of TGF-β1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells.
Hu S; Yu W; Lv TJ; Chang CS; Li X; Jin J
Mol Membr Biol; 2014; 31(2-3):103-10. PubMed ID: 24650126
[TBL] [Abstract][Full Text] [Related]
10. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
[TBL] [Abstract][Full Text] [Related]
11. Non-Cell-Autonomous Regulation of Prostate Epithelial Homeostasis by Androgen Receptor.
Zhang B; Kwon OJ; Henry G; Malewska A; Wei X; Zhang L; Brinkley W; Zhang Y; Castro PD; Titus M; Chen R; Sayeeduddin M; Raj GV; Mauck R; Roehrborn C; Creighton CJ; Strand DW; Ittmann MM; Xin L
Mol Cell; 2016 Sep; 63(6):976-89. PubMed ID: 27594448
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia.
Shao R; Shi J; Liu H; Shi X; Du X; Klocker H; Lee C; Zhu Y; Zhang J
Prostate; 2014 Jun; 74(9):970-82. PubMed ID: 24752964
[TBL] [Abstract][Full Text] [Related]
13. Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells.
Zhu ML; Kyprianou N
FASEB J; 2010 Mar; 24(3):769-77. PubMed ID: 19901020
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
15. NF-κB and androgen receptor variant expression correlate with human BPH progression.
Austin DC; Strand DW; Love HL; Franco OE; Jang A; Grabowska MM; Miller NL; Hameed O; Clark PE; Fowke JH; Matusik RJ; Jin RJ; Hayward SW
Prostate; 2016 Apr; 76(5):491-511. PubMed ID: 26709083
[TBL] [Abstract][Full Text] [Related]
16. Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells.
Popovics P; Schally AV; Salgueiro L; Kovacs K; Rick FG
Proc Natl Acad Sci U S A; 2017 Feb; 114(6):1359-1364. PubMed ID: 28123062
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor (AR) degradation enhancer ASC-J9
Cheng MA; Chou FJ; Wang K; Yang R; Ding J; Zhang Q; Li G; Yeh S; Xu D; Chang C
Cancer Lett; 2018 Mar; 417():182-191. PubMed ID: 29203251
[TBL] [Abstract][Full Text] [Related]
18. ASC-J9
Lin W; Luo J; Sun Y; Lin C; Li G; Niu Y; Chang C
Cancer Lett; 2018 Jul; 425():21-30. PubMed ID: 29425687
[TBL] [Abstract][Full Text] [Related]
19. Estradiol promotes epithelial-to-mesenchymal transition in human benign prostatic epithelial cells.
Shi X; Peng Y; Du X; Liu H; Klocker H; Lin Q; Shi J; Zhang J
Prostate; 2017 Oct; 77(14):1424-1437. PubMed ID: 28850686
[TBL] [Abstract][Full Text] [Related]
20. LPS/TLR4 Signaling Enhances TGF-β Response Through Downregulating BAMBI During Prostatic Hyperplasia.
He Y; Ou Z; Chen X; Zu X; Liu L; Li Y; Cao Z; Chen M; Chen Z; Chen H; Qi L; Wang L
Sci Rep; 2016 May; 6():27051. PubMed ID: 27243216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
